期刊
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
卷 19, 期 2, 页码 257-266出版社
IVYSPRING INT PUBL
DOI: 10.7150/ijms.67352
关键词
Hepatocellular carcinoma (HCC); MicroRNAs (miRNAs); FBXW7; Autophagy
资金
- Zhejiang Province Public Welfare Technology Application Research Project [LGF19H030017]
- Zhejiang Provincial Natural Science Foundation of China [LY19H160052]
MiR-25 increases sorafenib resistance of HCC cells by inducing autophagy and is associated with tumor pathological grade, clinic staging, and lymphatic metastasis, making it a potential novel therapeutic target for HCC treatment.
Sorafenib resistance is a major challenge in the treatment of patients with advanced hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) are a large family of non-coding RNA molecules, which is an important mechanism of drug resistance. We previously found that knockdown of miR-25 increased the sensitivity of TRAIL-induced apoptosis in liver cancer stem cells. We aimed to study the effects of miR-25 on sorafenib resistance of HCC and the underlying mechanisms. In the present study, we analyzed the expression of miR-25 between HCC and normal tissues and predicted miR-25 target genes through databases. After transfecting miR-25 mimics, inhibitor or FBXW7 Plasmid, CCK-8 and flow cytometry assay was performed to determine the sorafenib resistance. We performed LC3-dual-fluorescence assay and Western blotting to detect the autophagy levels. The expression of miR-25 was upregulated in human HCC tissues and was associated with tumor pathological grade, clinic staging, and lymphatic metastasis. MiR-25 enhanced sorafenib resistance of HCC cells and autophagy. FBXW7 is the direct target of miR-25. Overexpression of FBXW7 could reverse the increase of sorafenib resistance caused by miR-25 mimics. Our results suggested that miR-25 increased the sorafenib resistance of HCC via inducing autophagy. In addition, miR-25 decreases the expression of FBXW7 protein to regulate autophagy. Therefore, miR-25 may represent a novel therapeutic target for the treatment of HCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据